UA105827C2 - Normal;heading 1;heading 2;heading 3;HERAPEUTIC COMBINATION OF THEOBROMINE AND AN ANTIHISTAMINE ACTING ON H1-RECEPTOR - Google Patents
Normal;heading 1;heading 2;heading 3;HERAPEUTIC COMBINATION OF THEOBROMINE AND AN ANTIHISTAMINE ACTING ON H1-RECEPTORInfo
- Publication number
- UA105827C2 UA105827C2 UAA201208623A UAA201208623A UA105827C2 UA 105827 C2 UA105827 C2 UA 105827C2 UA A201208623 A UAA201208623 A UA A201208623A UA A201208623 A UAA201208623 A UA A201208623A UA 105827 C2 UA105827 C2 UA 105827C2
- Authority
- UA
- Ukraine
- Prior art keywords
- heading
- antihistamine
- theobromine
- herapeutic
- receptor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
An agent comprises theobromine and an antihistamine, as a combined preparation for simultaneous, sequential or separate use in therapy, particularly in the therapy of cough.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0921803.3A GB0921803D0 (en) | 2009-12-14 | 2009-12-14 | Drug composition and its use in therapy |
PCT/GB2010/052086 WO2011073647A1 (en) | 2009-12-14 | 2010-12-14 | Therapeutic combinations of theobromine and an antihistamine |
Publications (1)
Publication Number | Publication Date |
---|---|
UA105827C2 true UA105827C2 (en) | 2014-06-25 |
Family
ID=41667043
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201208623A UA105827C2 (en) | 2009-12-14 | 2010-12-14 | Normal;heading 1;heading 2;heading 3;HERAPEUTIC COMBINATION OF THEOBROMINE AND AN ANTIHISTAMINE ACTING ON H1-RECEPTOR |
Country Status (17)
Country | Link |
---|---|
EP (1) | EP2512472A1 (en) |
JP (2) | JP2013513652A (en) |
CN (1) | CN102802625A (en) |
AU (1) | AU2010332495C1 (en) |
BR (1) | BR112012014159A8 (en) |
CA (1) | CA2784215A1 (en) |
CO (1) | CO6541638A2 (en) |
GB (1) | GB0921803D0 (en) |
IL (1) | IL220384A0 (en) |
MX (1) | MX2012006624A (en) |
NZ (1) | NZ600267A (en) |
PE (1) | PE20121538A1 (en) |
RU (1) | RU2012129675A (en) |
SG (2) | SG10201408374WA (en) |
UA (1) | UA105827C2 (en) |
WO (1) | WO2011073647A1 (en) |
ZA (1) | ZA201204294B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0910375D0 (en) | 2009-06-16 | 2009-07-29 | Biocopea Ltd | Drug composition and its use in therapy |
US9314465B2 (en) | 2009-06-16 | 2016-04-19 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
US10016437B2 (en) | 2009-06-16 | 2018-07-10 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
US9308211B2 (en) | 2009-06-16 | 2016-04-12 | Infirst Healthcare Limited | Drug combinations and uses in treating a coughing condition |
GB201111485D0 (en) * | 2011-07-05 | 2011-08-17 | Biocopea Ltd | Drug composition and its use in therapy |
CN103263533B (en) * | 2013-05-31 | 2014-11-05 | 杨宏伟 | Theobromine composition for treating cough and application and preparation thereof |
CN104188998A (en) * | 2014-09-18 | 2014-12-10 | 中山大学 | Naringin and fexofenadine hydrochloride drug composition and preparation thereof |
CN104224819B (en) * | 2014-09-18 | 2016-08-17 | 中山大学 | A kind of naringin and levo-cetirizine hydrochloride pharmaceutical composition and preparation thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE59550T1 (en) * | 1986-04-17 | 1991-01-15 | Alza Corp | CHLORPHENIRAMINE THERAPY. |
HUP9700654A2 (en) | 1997-03-26 | 1999-09-28 | Dezső Korbonits | Antitussive compositions containing theobromine |
JPH10316568A (en) * | 1997-05-13 | 1998-12-02 | Taisho Pharmaceut Co Ltd | Pharmaceutical composition |
JP2003012514A (en) * | 2001-07-02 | 2003-01-15 | Taisho Pharmaceut Co Ltd | Medicament composition |
JP2003128549A (en) * | 2001-08-15 | 2003-05-08 | Rohto Pharmaceut Co Ltd | Composition applicable to mucous membrane |
US20080003280A1 (en) * | 2006-06-26 | 2008-01-03 | Levine Brian M | Combination cough treatment compounds and method of treating common coughs |
JP2010523695A (en) * | 2007-04-11 | 2010-07-15 | アルコン リサーチ, リミテッド | Use of inhibitors of TNFα and antihistamines to treat allergic rhinitis and allergic conjunctivitis |
-
2009
- 2009-12-14 GB GBGB0921803.3A patent/GB0921803D0/en not_active Ceased
-
2010
- 2010-12-14 CA CA2784215A patent/CA2784215A1/en not_active Abandoned
- 2010-12-14 CN CN2010800570274A patent/CN102802625A/en active Pending
- 2010-12-14 JP JP2012543903A patent/JP2013513652A/en active Pending
- 2010-12-14 AU AU2010332495A patent/AU2010332495C1/en not_active Ceased
- 2010-12-14 PE PE2012000814A patent/PE20121538A1/en not_active Application Discontinuation
- 2010-12-14 SG SG10201408374WA patent/SG10201408374WA/en unknown
- 2010-12-14 MX MX2012006624A patent/MX2012006624A/en not_active Application Discontinuation
- 2010-12-14 WO PCT/GB2010/052086 patent/WO2011073647A1/en active Application Filing
- 2010-12-14 RU RU2012129675/15A patent/RU2012129675A/en not_active Application Discontinuation
- 2010-12-14 BR BR112012014159A patent/BR112012014159A8/en not_active IP Right Cessation
- 2010-12-14 EP EP10796123A patent/EP2512472A1/en not_active Ceased
- 2010-12-14 NZ NZ600267A patent/NZ600267A/en not_active IP Right Cessation
- 2010-12-14 UA UAA201208623A patent/UA105827C2/en unknown
- 2010-12-14 SG SG2012042495A patent/SG181603A1/en unknown
-
2012
- 2012-06-12 ZA ZA2012/04294A patent/ZA201204294B/en unknown
- 2012-06-12 CO CO12098529A patent/CO6541638A2/en unknown
- 2012-06-13 IL IL220384A patent/IL220384A0/en unknown
-
2015
- 2015-09-28 JP JP2015189277A patent/JP6078605B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN102802625A (en) | 2012-11-28 |
PE20121538A1 (en) | 2012-12-21 |
NZ600267A (en) | 2013-07-26 |
RU2012129675A (en) | 2014-01-27 |
GB0921803D0 (en) | 2010-01-27 |
CA2784215A1 (en) | 2011-06-23 |
JP6078605B2 (en) | 2017-02-08 |
SG181603A1 (en) | 2012-07-30 |
WO2011073647A1 (en) | 2011-06-23 |
BR112012014159A8 (en) | 2017-12-26 |
AU2010332495C1 (en) | 2016-02-11 |
BR112012014159A2 (en) | 2017-08-29 |
SG10201408374WA (en) | 2015-01-29 |
MX2012006624A (en) | 2012-10-05 |
ZA201204294B (en) | 2013-02-27 |
AU2010332495A1 (en) | 2012-06-21 |
CO6541638A2 (en) | 2012-10-16 |
AU2010332495B2 (en) | 2015-01-22 |
JP2013513652A (en) | 2013-04-22 |
JP2016040280A (en) | 2016-03-24 |
IL220384A0 (en) | 2012-08-30 |
EP2512472A1 (en) | 2012-10-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA105827C2 (en) | Normal;heading 1;heading 2;heading 3;HERAPEUTIC COMBINATION OF THEOBROMINE AND AN ANTIHISTAMINE ACTING ON H1-RECEPTOR | |
NZ619520A (en) | Antidiabetic medications comprising a dpp-4 inhibitor (linagliptin) optionally in combination with other antidiabetics | |
UA96124C2 (en) | Pharmaceutical foam formulation copmprising imiquimod | |
AP2507A (en) | Quinoline derivatives and use thereof as mycobacterial inhibitors. | |
PL2679676T3 (en) | Methods and organisms for the growth-coupled production of 1,4-butanediol | |
IL180872A0 (en) | Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv | |
TNSN08178A1 (en) | Triazolopyridine derivatives as inhibitors of lipases and phospholipases | |
UA93903C2 (en) | Tetrahydroisoquinoline derivatives to enhance memory function | |
MX362442B (en) | Ire-1-alpha inhibitors. | |
MX343598B (en) | Theobromine in combination with an expectorant or a mucolytic for use in therapy. | |
TW200631584A (en) | A medicament related to mirtazapine for the treatment of hot flush | |
PL2410047T3 (en) | Oxidoreductase and its use for the reduction of secodione derivatives | |
WO2009149058A3 (en) | Modified release niacin formulations | |
UA111324C2 (en) | Pigmentation-preventing or -ameliorating agent | |
WO2011058373A3 (en) | Drug combination with theobromine and its use in therapy | |
MX343222B (en) | Combination of theobromine with a decongestant and its use for the treatment of cough. | |
AU321417S (en) | Restraint device | |
WO2012054093A3 (en) | Acyl piperidine inhibitors of soluble epoxide hydrolase | |
UA105940C2 (en) | Drug formulation with theobromine and opiate for treatment of cough | |
WO2010120817A3 (en) | Nanochanneled device and related methods | |
GB2492923A (en) | Catheter having inflation and deflation lumen useful for preventing or reducing reperfusion injury | |
MX2012005849A (en) | Immunomodulatory compounds for the restoration of vitamin d sensitivity in vitamin d resistant tumor cells. | |
TW200635934A (en) | Amorphous tacrolimus and preparation thereof | |
WO2012040444A3 (en) | Treatment of patients with incipient alzheimer's disease | |
WO2008122794A3 (en) | Breast cancer methods, medicaments and agents |